-
Human Longevity Launches Whole Genome Product, MassMutual Partnerships
Bio-IT World | Human Longevity, Inc. and Massachusetts Mutual Life Insurance Co. announced an agreement to offer HLI's new whole genome sequencing product, HLIQ Whole Genome, to eligible MassMutual customers, employees, and financial professionals at a reduced price.
Mar 20, 2017
-
Nvidia And Bosch Team Up On Self-Driving Car AI Supercomputer
TechCrunch | Nvidia's new partner in bringing AI-powered self-driving tech to the masses definitely has the experience needed to go truly mass-market - it's Bosch.
Mar 17, 2017
-
Trump Administration Proposes Big Cuts In Medical Research Shots - Health News
NPR.org | The National Institutes of Health, which funds research in treatments and cures, could lose 20 percent of its budget under the administration's proposal. More money would go for addiction treatment.
Mar 16, 2017
-
Allergan And Editas Medicine Enter Into R&D Alliance
Bio-IT World Brief | Allergan and Editas Medicine have announced that they have entered into a strategic research and development alliance under which Allergan will receive exclusive access and the option to license up to five of Editas Medicine’s genome-editing ocular programs.
Mar 15, 2017
-
Oxford Nanopore Announces New Sequencing System, Certification Program
Bio-IT World Brief | Oxford Nanopore announced the launch of the GridION X5 today, a new system that can drive up to five MinION Flow Cells and process all the data produced within a single benchtop device.
Mar 15, 2017
-
GWAS Study Identifies Variant In African Populations Tied To Obesity
Bio-IT World Brief | An international team of researchers has conducted the first study of its kind to look at the genomic underpinnings of obesity in continental Africans and African Americans.
Mar 14, 2017
-
Qatar Genome Programme Launches Research Consortium
Bio-IT World Brief | More than 90 genomics researchers gathered recently for the launch of the Qatar Genome Programme’s research consortium (QGPRC). The consortium is the latest step in QGP’s precision medicine implementation efforts.
Mar 13, 2017
-
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed?
Xconomy | This seems to be a watershed year for CAR-T therapy. The field's first-ever regulatory approval is looking like a strong possibility. However, the supercharged T cells remain an enigma.
Mar 13, 2017
